Results 21 to 30 of about 7,433 (164)

Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study

open access: yesThe Pan African Medical Journal, 2019
INTRODUCTION: Infantile hemangioma is the most common benign tumor in infancy. Currently, oral propranolol is the treatment of choice for infantile hemangioma, but there is no consensus when it comes to its recommended dosage for this condition.
Arun Prasad   +4 more
doaj   +1 more source

Infantile hemangioma in a V2 distribution: Treatment with nadolol

open access: yesJournal of Family Medicine and Primary Care, 2015
Infantile hemangiomas are common benign tumours of infancy affecting up to 10% of children. They are typically not present at birth but undergo a rapid proliferation stage and then plateau in growth before resolving spontaneously. Recently, beta-blockers
Mariah Giberson, Robert Hayes
doaj   +1 more source

The Efficacy of Polidocanol foam Sclerotherapy in Treatment of Infantile Hemangioma and Slow-Flow Vascular Malformation

open access: yesJournal of Baghdad College of Dentistry, 2016
Background: Sclerotherapy is a simple treatment modality for treatment of infantile hemangioma and slow-flow vascular malformations; Polidocanol is a mild sclerosing agent that is traditionally used in treatment of varicose veins.
Suhail Ibraheem Kadhum   +1 more
doaj   +1 more source

Infantile hepatic hemangioma: a diagnostic dilemma

open access: yesRussian Open Medical Journal, 2014
Infantile hepatic hemangioma is a tumor arising from the mesenchymal liver tissue. Presentation varies from being asymptomatic to having life threatening complications. They can manifest as solitary or multicentric lesions.
Fehmida Najmuddin   +4 more
doaj   +1 more source

Progress in evidence-based research on the clinical treatment of infantile hemangioma and vascular malformations

open access: yes口腔疾病防治, 2021
Hemangiomas and vascular malformations are common clinical diseases. According to their clinical and imaging characterizations, the International Society for the Study of Vascular Anomalies (ISSVA) has systematically classified infantile hemangioma and ...
ZHENG Jiawei, ZHAO Zeliang
doaj   +1 more source

Targeted Medical Therapies for Vascular Anomalies: A Clinical Review

open access: yesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT Vascular anomalies represent a broad spectrum of disorders characterized by aberrant blood or lymphatic vessel development, which can lead to complex clinical phenotypes. Historically, vascular anomalies were classified solely on the basis of their clinical and histopathologic features.
Whitney Eng
wiley   +1 more source

Clinical characteristics of infantile haemangioma in twins: a retrospective study

open access: yesBMC Pediatrics
Background Infantile hemangioma is one of the most common benign soft tissue tumors in infants. The pathogenesis of infantile hemangioma remains unclear and twin studies regarding its incidence may help clarify disease pathogenesis.
Zhengwei Sun   +3 more
doaj   +1 more source

Three-Dimensional Microtumor Formation of Infantile Hemangioma-Derived Endothelial Cells for Mechanistic Exploration and Drug Screening

open access: yesPharmaceuticals, 2022
Infantile hemangioma (IH) is the most prevalent type of vascular tumor in infants. The pathophysiology of IH is unknown. The tissue structure and physiology of two-dimensional cell cultures differ greatly from those in vivo, and spontaneous regression ...
Yanan Li   +5 more
doaj   +1 more source

Klippel‐Trénaunay‐Weber Syndrome: Prenatal Diagnosis and Review of the Literature

open access: yesJournal of Clinical Ultrasound, Volume 53, Issue 3, Page 535-546, March/April 2025.
This meta‐analysis demonstrates the high diagnostic accuracy of SZ‐CEUS for differentiating between malignant and benign focal liver lesions, as well as for HCC from non‐HCC lesions. The study shows better performance for smaller lesions and those with a higher proportion of malignancy.
Giuliana Orlandi   +13 more
wiley   +1 more source

NOGOB receptor–mediated RAS signaling pathway is a target for suppressing proliferating hemangioma

open access: yesJCI Insight, 2021
Infantile hemangioma is a vascular tumor characterized by the rapid growth of disorganized blood vessels followed by slow spontaneous involution. The underlying molecular mechanisms that regulate hemangioma proliferation and involution still are not well
Wenquan Hu   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy